{
    "Trade/Device Name(s)": [
        "Tyson Bio HT100 Blood Glucose Monitoring System",
        "Tyson Bio HT100-B Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tyson Bioresearch, Inc.",
    "510(k) Number": "k170079",
    "Predicate Device Reference 510(k) Number(s)": [
        "k133741"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "September 7, 2017",
    "Summary Letter Received Date": "September 8, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Tyson Bio HT100 Blood Glucose Meter",
        "Tyson Bio HT100-B Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Tyson Bio HT100 and HT100-B Blood Glucose Monitoring Systems using electrochemical biosensor technology for self-monitoring of blood glucose in diabetic patients.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm for self-testing by people with diabetes to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}